METHOD AND KIT FOR PREDICTING OR MONITORING THE RESPONSE OF A CANCER PATIENT TO CHEMOTHERAPY, BASED ON MEASURING THE EXPRESSION LEVEL OF TMEM45A GENE.

Carine Michiels,; Lionel Flamant,

METHOD AND KIT FOR PREDICTING OR MONITORING THE RESPONSE OF A CANCER PATIENT TO CHEMOTHERAPY, BASED ON MEASURING THE EXPRESSION LEVEL OF TMEM45A GENE.

Carine Michiels, (Inventor), Lionel Flamant, (Inventor)

Research output: Patent

Abstract

A method for prognosticating the outcome of a cancer, for predicting the response to a chemotherapy treatment of a cancer or for monitoring the response to a chemotherapy treatment of a cancer, comprising the step of measuring the expression level of TMEM45A gene in a sample

Translated title of the contribution	MÉTHODE ET TROUSSE PERMETTANT DE PRÉDIRE OU DE SURVEILLER LA RÉACTION D'UN PATIENT CANCÉREUX À LA CHIMIOTHÉRAPIE, À PARTIR DE LA MESURE DU NIVEAU D'EXPRESSION DU GÈNE TMEM45A
Original language	English
Patent number	WO2014009055
IPC	C12Q 1/ 68 A I
Priority date	22/02/13
Publication status	Published - 16 Jan 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@misc{75d48542774943bda19196ab6548a693,

title = "METHOD AND KIT FOR PREDICTING OR MONITORING THE RESPONSE OF A CANCER PATIENT TO CHEMOTHERAPY, BASED ON MEASURING THE EXPRESSION LEVEL OF TMEM45A GENE.",

abstract = "A method for prognosticating the outcome of a cancer, for predicting the response to a chemotherapy treatment of a cancer or for monitoring the response to a chemotherapy treatment of a cancer, comprising the step of measuring the expression level of TMEM45A gene in a sample",

author = "Carine Michiels, and Lionel Flamant,",

year = "2014",

month = jan,

day = "16",

language = "English",

type = "Patent",

note = "WO2014009055; C12Q 1/ 68 A I",

}

TY - PAT

T1 - METHOD AND KIT FOR PREDICTING OR MONITORING THE RESPONSE OF A CANCER PATIENT TO CHEMOTHERAPY, BASED ON MEASURING THE EXPRESSION LEVEL OF TMEM45A GENE.

AU - Michiels,, Carine

AU - Flamant,, Lionel

PY - 2014/1/16

Y1 - 2014/1/16

N2 - A method for prognosticating the outcome of a cancer, for predicting the response to a chemotherapy treatment of a cancer or for monitoring the response to a chemotherapy treatment of a cancer, comprising the step of measuring the expression level of TMEM45A gene in a sample

AB - A method for prognosticating the outcome of a cancer, for predicting the response to a chemotherapy treatment of a cancer or for monitoring the response to a chemotherapy treatment of a cancer, comprising the step of measuring the expression level of TMEM45A gene in a sample

M3 - Patent

M1 - WO2014009055

ER -

METHOD AND KIT FOR PREDICTING OR MONITORING THE RESPONSE OF A CANCER PATIENT TO CHEMOTHERAPY, BASED ON MEASURING THE EXPRESSION LEVEL OF TMEM45A GENE.

Abstract

UN SDGs

Fingerprint

Cite this